This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
National Medical Products Administration. Announcement on further promoting post-marketing research and evaluation of TCM injections (draft for comment). https://go.nature.com/4ryDz5V (2025).
Center for Drug Evaluation. Technical requirements for post-marketing research and evaluation of TCM injections (draft for comment). NMPA https://go.nature.com/3K4Eiew (2025).
World Health Organization. Global Traditional Medicine Strategy 2025–2034 (WHO, 2025).
Wang, A. et al. JAMA Neurol. 80, 851–859 (2023).
Liu, F. et al. J. Ethnopharmacol. 353 (Part B), 120413 (2025).
Acknowledgements
The authors are supported by the Four Batches Innovation Project of Invigorating Medical through Science and Technology of Shanxi Province (2022XM07), and the Shanxi Province Chinese Medicine Science and Technology special research project (2024ZYY2A023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Chen, C., Hou, Z. China’s evidence-based re-evaluation of traditional Chinese medicine injections. Nat Med (2026). https://doi.org/10.1038/s41591-025-04122-7
Published:
Version of record:
DOI: https://doi.org/10.1038/s41591-025-04122-7